Form 8-K - Current report:
SEC Accession No. 0001104659-25-021973
Filing Date
2025-03-10
Accepted
2025-03-10 07:30:22
Documents
20
Period of Report
2025-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258581d1_8k.htm   iXBRL 8-K 89290
2 EXHIBIT 2.1 tm258581d1_ex2-1.htm EX-2.1 1015281
3 EXHIBIT 3.1 tm258581d1_ex3-1.htm EX-3.1 4834
4 EXHIBIT 4.1 tm258581d1_ex4-1.htm EX-4.1 18603
5 EXHIBIT 10.1 tm258581d1_ex10-1.htm EX-10.1 125548
6 EXHIBIT 99.1 tm258581d1_ex99-1.htm EX-99.1 74993
10 GRAPHIC tm258581d1_ex99-1img001.jpg GRAPHIC 3597
11 GRAPHIC tm258581d1_ex99-1img002.jpg GRAPHIC 4277
  Complete submission text file 0001104659-25-021973.txt   1818435

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20250309.xsd EX-101.SCH 3027
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20250309_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20250309_pre.xml EX-101.PRE 22367
22 EXTRACTED XBRL INSTANCE DOCUMENT tm258581d1_8k_htm.xml XML 3805
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

EIN.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 25722147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)